27114 Federal Register / Vol. 60, No. 98 / Monday, May 22, 1995 / Notices

187. Debra Klein on behalf of Gary

Klein, Jr., Deceased, Glen Carbon,

Illinois, Claims Court Number 91–

1548 V

188. Velma Cullinane on behalf of Kyle

Cullinane, Deceased, Boston,

Massachusetts, Claims Court Number

91–1554 V

189. Marc Plavin on behalf of Rachel

Reiss-Plavin, Lexington, Kentucky,

Claims Court Number 91–1555 V

190. Martha Steenbruggen on behalf of

Dana Steenbrugen, Reading,

Massachusetts, Claims Court Number

91–1557 V

191. Michele Moore on behalf of

Jonathan Amorella-Moore, Reading,

Massachusetts, Claims Court Number

91–1558 V

192. Michael Stephens on behalf of

Matthew Stephens, Houston, Texas,

Claims Court Number 91–1565 V

193. Ida Rasmussen, Westland,

Michigan, Claims Court Number 91–

1566 V

194. Donella Raspberry on behalf of

Shanelle Eastling, Deceased, Baldwin,

Michigan, Claims Court Number 91–

1567 V

195. Pradeep Nayyar on behalf of Geeta

Nayyar, Old Bridge, New Jersey,

Claims Court Number 91–1583 V

196. Rodney Jones, Chicago, Illinois,

Claims Court Number 91–1590

197. Lori Barton on behalf of Dustin

Barton, Albuquerque, New Mexico,

Claims Court Number 91–1594

198. Michele Bartl on behalf of Caitlyn

Bartl, Foley, Alabama, Claims Court

Number 91–1595

199. Donna DeFazio, Staten Island, New

York, Claims Court Number 91–1597

200. Barbara Toebe on behalf of Anne

Toebe, Paoli, Pennsylvania, Claims

Court Number 91–1623.

Dated: May 16, 1995.

Ciro V. Sumaya,

Administrator.

[FR Doc. 95–12453 Filed 5–19–95; 8:45 am]

BILLING CODE 4160–15–P

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Meeting:

AIDS Research Advisory Committee,

NIAID

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the AIDS Research Advisory Committee,

National Institute of Allergy and

Infectious Diseases, on June 6–7, 1995,

in the Grand Ballroom of the

Gaithersburg Hilton Hotel, 620 Perry

Parkway, Gaithersburg, Maryland.

The entire meeting will be open to the

public from 8 a.m. until recess on June

6, and from 8 a.m. until adjournment on

June 7. The AIDS Research Advisory

Committee (ARAC) advises and makes

recommendations to the Director,

National Institute of Allergy and

Infectious Diseases, on all aspects of

research on HIV and AIDS related to the

mission of the Division of AIDS

(DAIDS).

The Committee will provide advice

on scientific priorities, policy, and

program balance at the Division level.

The Committee will review the progress

and productivity of ongoing efforts, and

identify critical gaps/obstacles to

progress. Attendance by the public will

be limited to space available.

Ms. Anne P. Claysmith, Executive

Secretary, AIDS Research Advisory

Committee, DAIDS, NIAID, NIH, Solar

Building, Room 2B06, telephone 301–

402–0755, will provide a summary of

the meeting and a roster of committee

members upon request. Individuals who

plan to attend and need special

assistance, such as sign language

interpretation or other reasonable

accommodations, should contact Ms.

Claysmith in advance of the meeting.

(Catalog of Federal Domestic Assistance

Program Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health.)

Dated: May 15, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–12403 Filed 5–19–95; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Child Health and

Human Development; Notice of

Meetings

Pursuant to Pub. L. 92–463, notice is

hereby given of meetings of the review

committees of the National Institute of

Child Health and Human Development

for June 1995.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

and sec. 10(d) of Pub. L. 92–463, for the

review, discussion and evaluation of

individual grant applications. These

applications and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material, and

personal information concerning individuals

associated with the applications, the

disclosure of which would constitute a

clearly unwarranted invasion of personal

privacy.

Name of Committee: Population Research

Committee.

Scientific Review Administrator: Dr. A.T.

Gregoire, 6100 Executive Boulevard—Rm.

5E03, Telephone: 301–496–1696.

Date of Meeting: June 8–9, 1995.

Place of Meeting: Holiday Inn—Bethesda,

8120 Wisconsin Avenue, Bethesda, Maryland

20814, Georgia Room.

Time: June 8–8:00 am–5:00 p.m. June 9–

8:00 am–adjournment.

Name of Committee: Maternal and Child

Health Research Committee.

Scientific Review Administrator: Dr. Gopal

Bhatnagar, 6100 Executive Boulevard—Rm.

5E03, Telephone: 301–496–1485.

Date of Meeting: June 12–13, 1995.

Place of Meeting: Holiday Inn—

Gaithersburg, #2 Montgomery Village

Avenue, Gaithersburg, Maryland 20879.

Time: June 12–8:00 am–5:00 p.m. June 13–

8:00 am–adjournment.

Name of Committee: Mental Retardation

Research Committee.

Scientific Review Administrator: Dr.

Norman Chang, 6100 Executive Boulvard—

Rm. 5E03, Telephone: 301–496–1485.

Date of Meeting: June 23–24, 1995.

Place of Meeting: Holiday Inn Crowne

Plaza, 1750 Rockville Pike, Rockville,

Maryland 20852.

Time: June 23–8:00 am–5:00 p.m. June 24–

8:00 am–adjournment.

(Catalog of Federal Domestic Assistance

Program No. 93.864, Population Research

and No. 93.865, Research for Mothers and

Children, National Institutes of Health.)

Dated: May 15, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–12404 Filed 5–19–95; 8:45 am]

BILLING CODE 4140–01–M

National Institute of General Medical

Sciences; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings:

Purpose: To review grant applications.

Committee Name: National Institute of

General Medical Sciences, Cellular and

Molecular Basis of Disease Review

Committee.

Date: June 7.

Time: 8:30 a.m.—5 p.m.

Place: 45 Center Drive, Conference Room

B, Bethesda, MD 20892–62000.

Contact Person: Dr. Carole Latker,

Scientific Review Administrator, NIGMS, 45

Center Drive, Room 1AS–13K, Bethesda, MD

20892–62000.

Committee Name: National Institute of

General Medical Sciences, Pharmacological

Sciences Review Committee.

Date: June 7.

Time: 8:30 a.m.—5 p.m.

Place: 45 Center Drive, Conference Room

G1 and G2, Bethesda, MD 20892–6200.

Contact Person: Dr. Irene Glowinski,

Scientific Review Administrator, NIGMS, 45

Center Drive, Room 1 AS–13J, Bethesda, MD

20892–6200.

Committee Name: National Institute of

General Medical Sciences, Genetic Basis of

Disease Review Committee.
Federal Register / Vol. 60, No. 98 / Monday, May 22, 1995 / Notices 27115

Date: June 12.

Time: 8:30 a.m.—adjournment.

Place: Holiday Inn, 5520 Wisconsin

Avenue, Chevy Chase, MD 20815.

Contact Person: Dr. Arthur Zachary,

Scientific Review Administrator, NIGMS, 45

Center Drive, Room 1AS–13H, Bethesda, MD

20892–6200.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552(c)(6), Title 5, U.S.C.

The discussions of these applications could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

This notice is being published less than

fifteen days prior to the first meeting due to

the urgent need to meet timing limitations

imposed by the grant review cycle.

(Catalog of Federal Domestic Assistance

Program Nos. 93,821, Biophysics and

Physiological Sciences; 93.859,

Pharmacological Sciences; 93.862 Genetics

Research; 93.863, Cellular and Molecular

Basis of Disease Research; 93.880, Minority

Access Research Careers [MARC]; and

93.375, Minority Biomedical Research

Support [MBRS].

Dated: May 15, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–12400 Filed 5–19–95; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Mental Health;

Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the meetings of the

National Institute of Mental Health:

Agenda/Purpose: To review and evaluate

grant applications.

Committee Name: National Institute of

Mental Health Initial Review Group, Clinical

Centers and Special Projects Review

Committee.

Date: June 5–9, 1995.

Time: 7:00 p.m.

Place: Ramada Inn Rockville, 1775

Rockville Pike, Rockville, MD 20852.

Contact Person: Phyllis L. Zusman, Grant

Technical Assistant, Parklawn Building,

Room 9C–18, 5600 Fishers Lane, Rockville,

MD 20857, Telephone: 301, 443–1340.

Committee Name: National Institute of

Mental Health Special Emphasis Panel.

Date: June 19, 1995.

Time: 2:00 p.m.

Place: Parklawn Building, Room 9C–26,

5600 Fishers Lane, Rockville, MD 20857.

Contact Person: Regina M. Thomas, Grant

Technical Assistant, Parklawn Building,

Room 9C–26, 5600 Fishers Lane, Rockville,

MD 20857, Telephone: 301, 443–6470.

Committee Name: National Institute of

Mental Health Special Emphasis Panel.

Date: June 20, 1995.

Time: 1:30 p.m.

Place: Parklawn Building, Room 9C–26,

5600 Fishers Lane, Rockville, MD 20857.

Contact Person: Rehana A. Chowdhury,

Grant Technical Assistant, Parklawn

Building, Room 9C–26, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301, 443–

6470.

Agenda/Purpose: To review for final

approval recent views of selected intramural

research projects.

Committee Name: Board of Scientific

Counselors, National Institute of Mental

Health.

Date: June 13–14, 1995.

Time: 9:00 a.m.

Place: Building 36, Room 1B07, National

Institute of Health, 9000 Rockville Pike,

Bethesda, MD 20892.

Contact Person: Jack D. Maser, Ph.D.,

Executive Secretary, Building 10, Room

4N224, 9000 Rockville Pike, Bethesda, MD

20982, Telephone: 301, 496–4183.

The meetings will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

These applications, research project reviews,

and the discussions could reveal confidential

trade secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and projects, the disclosure of

which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than

fifteen days prior to the meetings due to the

urgent need to meeting timing limitations

imposed by the review cycle.

(Catalog of Federal Domestic Assistance

Program Numbers 93.126, Small Business

Innovation Research; 93.176, ADAMHA

Small Instrumentation Program Grants;

93.242, Mental Health Research Grants;

93.281, Mental Research Scientist

Development Award and Research Scientist

Development Award for Clinicians; 93.282,

Mental Health Research Service Awards for

Research Training; and 93.921, ADAMHA

Science Education Partnership Award.)

Dated: May 15, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–12401 Filed 5–19–95; 8:45 am]

BILLING CODE 4140–01–M

Ad Hoc Review Committee for the

Recombinant DNA Advisory

Committee; Notice of Meeting

Notice is hereby given of a meeting of

the Ad Hoc Review Committee for the

Recombinant DNA Advisory Committee

on June 19, 1995, at the National

Institutes of Health, Building 31C, 6th

Floor, Conference Room 8, 9000

Rockville Pike, Bethesda, Maryland

20892, starting at approximately 9 a.m.

to adjournment at approximately 5 p.m.

The meeting will be open to the public

to discuss three major topics for review:

(1) Domain and mandate of the

Recombinant DNA Advisory Committee;

(2) composition of the Recombinant

DNA Advisory Committee; and (3)

Recombinant DNA Advisory

Committee’s review of human gene

transfer protocols. Attendance by the

public will be limited to space available.

Members of the public wishing to speak

at this meeting may be given such

opportunity at the discretion of the

Chair.

Dr. Nelson A. Wivel, Director, Office

of Recombinant DNA Activities, Suite

323, National Institutes of Health, 6006

Executive Boulevard, MSC 7052,

Bethesda, Maryland 20892–7052, Phone

(301) 496–9838, FAX (301) 496–9839,

will provide materials to be discussed at

this meetings, roster of committee

members and substantive program

information. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

contact Dr. Wivel in advance of the

meeting. A summary of the meeting will

be available at a later date.

OMB’s ‘‘Mandatory Information

Requirements for Federal Assistance

Program Announcements’’ (45 FR

39592, June 11, 1980) requires a

statement concerning the official

government programs contained in the

Catalog of Federal Domestic Assistance.

Normally NIH lists in its

announcements the number of title of

affected individual programs for the

guidance of the public. Because the

guidance in this notice covers not only

virtually every NIH program but also

essentially every Federal research

program in which DNA recombinant

molecule techniques could be used, it

has been determined not to be cost

effective or in the public interest to

attempt to list these programs. Such a

list would likely require several

additional pages. In addition, NIH could

not be certain that every Federal

program would be included as many

Federal agencies, as well as private

organizations, both national and

international, have elected to follow the

NIH Guidelines. In lieu of the

individual program listing, NIH invites

readers to direct questions to the

information address above about

whether individual programs listed in

the Catalog of Federal Domestic

Assistance are affected.

Dated: May 15, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–12402 Filed 5–19–95; 8:45 am]

BILLING CODE 4140–01–M